Alia Al-Tayyib
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 11 | 2026 | 131 | 2.690 |
Why?
| | Amphetamine-Related Disorders | 6 | 2026 | 53 | 2.080 |
Why?
| | Methamphetamine | 7 | 2026 | 75 | 1.980 |
Why?
| | Opioid-Related Disorders | 8 | 2025 | 611 | 1.800 |
Why?
| | Homosexuality, Male | 9 | 2026 | 231 | 1.640 |
Why?
| | HIV Infections | 23 | 2026 | 3210 | 1.310 |
Why?
| | Hepatitis C | 8 | 2026 | 250 | 1.170 |
Why?
| | Methadone | 2 | 2025 | 130 | 1.070 |
Why?
| | Patient Navigation | 2 | 2026 | 126 | 1.020 |
Why?
| | Opiate Substitution Treatment | 3 | 2025 | 195 | 0.990 |
Why?
| | Analgesics, Opioid | 6 | 2025 | 1158 | 0.960 |
Why?
| | Prescription Drug Misuse | 2 | 2017 | 53 | 0.880 |
Why?
| | Gonorrhea | 4 | 2012 | 63 | 0.860 |
Why?
| | Sexual Behavior | 10 | 2022 | 489 | 0.850 |
Why?
| | Heroin Dependence | 2 | 2017 | 33 | 0.810 |
Why?
| | Drug Overdose | 6 | 2026 | 376 | 0.790 |
Why?
| | Chlamydia Infections | 5 | 2012 | 79 | 0.720 |
Why?
| | Transgender Persons | 1 | 2026 | 213 | 0.720 |
Why?
| | Emergency Service, Hospital | 13 | 2025 | 2357 | 0.720 |
Why?
| | Colorado | 15 | 2026 | 4588 | 0.660 |
Why?
| | Unsafe Sex | 4 | 2017 | 62 | 0.630 |
Why?
| | Needle-Exchange Programs | 3 | 2026 | 16 | 0.620 |
Why?
| | Sexual Partners | 6 | 2018 | 195 | 0.610 |
Why?
| | Mass Screening | 11 | 2025 | 1300 | 0.600 |
Why?
| | Internet | 2 | 2017 | 656 | 0.560 |
Why?
| | Substance-Related Disorders | 6 | 2025 | 1098 | 0.530 |
Why?
| | Buprenorphine | 1 | 2021 | 197 | 0.530 |
Why?
| | Adult | 42 | 2026 | 40821 | 0.530 |
Why?
| | Hepacivirus | 5 | 2025 | 236 | 0.490 |
Why?
| | Cities | 5 | 2026 | 140 | 0.450 |
Why?
| | Male | 48 | 2026 | 73014 | 0.450 |
Why?
| | Prescription Drugs | 1 | 2016 | 110 | 0.430 |
Why?
| | Middle Aged | 27 | 2026 | 36359 | 0.420 |
Why?
| | Mobile Applications | 1 | 2017 | 193 | 0.410 |
Why?
| | Health Services Accessibility | 5 | 2026 | 1101 | 0.390 |
Why?
| | Homeless Youth | 1 | 2013 | 23 | 0.390 |
Why?
| | Young Adult | 18 | 2026 | 14240 | 0.370 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 283 | 0.370 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2026 | 1403 | 0.360 |
Why?
| | Socioeconomic Factors | 7 | 2026 | 1323 | 0.350 |
Why?
| | Primary Prevention | 1 | 2014 | 222 | 0.350 |
Why?
| | Humans | 56 | 2026 | 145625 | 0.350 |
Why?
| | Female | 39 | 2026 | 79080 | 0.350 |
Why?
| | Risk-Taking | 8 | 2020 | 321 | 0.350 |
Why?
| | Adolescent | 22 | 2026 | 22451 | 0.340 |
Why?
| | Public Health | 1 | 2016 | 573 | 0.330 |
Why?
| | United States | 21 | 2026 | 16041 | 0.320 |
Why?
| | Pre-Exposure Prophylaxis | 2 | 2026 | 272 | 0.300 |
Why?
| | Social Stigma | 2 | 2022 | 174 | 0.300 |
Why?
| | Comorbidity | 3 | 2021 | 1652 | 0.290 |
Why?
| | Attitude | 1 | 2011 | 253 | 0.290 |
Why?
| | Heterosexuality | 3 | 2018 | 49 | 0.280 |
Why?
| | Telephone | 2 | 2009 | 175 | 0.280 |
Why?
| | Safety-net Providers | 2 | 2020 | 132 | 0.280 |
Why?
| | Heroin | 2 | 2020 | 30 | 0.270 |
Why?
| | Prevalence | 6 | 2019 | 2852 | 0.270 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 6050 | 0.260 |
Why?
| | Self Disclosure | 2 | 2009 | 62 | 0.240 |
Why?
| | Financing, Government | 1 | 2026 | 53 | 0.230 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 632 | 0.230 |
Why?
| | Models, Economic | 1 | 2025 | 63 | 0.220 |
Why?
| | Interviews as Topic | 4 | 2024 | 926 | 0.210 |
Why?
| | Housing | 1 | 2025 | 141 | 0.210 |
Why?
| | Psychoses, Substance-Induced | 1 | 2024 | 16 | 0.210 |
Why?
| | Chlamydia trachomatis | 3 | 2008 | 49 | 0.200 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 55 | 0.190 |
Why?
| | Prospective Studies | 7 | 2026 | 8087 | 0.190 |
Why?
| | Health Care Costs | 1 | 2026 | 418 | 0.180 |
Why?
| | Baltimore | 3 | 2008 | 71 | 0.180 |
Why?
| | Health Surveys | 2 | 2009 | 511 | 0.170 |
Why?
| | Family Planning Services | 1 | 2022 | 93 | 0.170 |
Why?
| | Insurance, Health | 2 | 2015 | 315 | 0.170 |
Why?
| | Needle Sharing | 1 | 2020 | 10 | 0.160 |
Why?
| | Educational Status | 1 | 2002 | 466 | 0.160 |
Why?
| | Patient-Centered Care | 1 | 2025 | 551 | 0.150 |
Why?
| | Risk | 2 | 2016 | 917 | 0.150 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 268 | 0.150 |
Why?
| | Drug Users | 1 | 2020 | 43 | 0.150 |
Why?
| | Allied Health Personnel | 1 | 2020 | 54 | 0.150 |
Why?
| | Washington | 2 | 2020 | 157 | 0.140 |
Why?
| | Neisseria gonorrhoeae | 2 | 2008 | 29 | 0.140 |
Why?
| | Anti-HIV Agents | 1 | 2026 | 914 | 0.130 |
Why?
| | HIV | 3 | 2019 | 249 | 0.130 |
Why?
| | Cohort Studies | 3 | 2025 | 6045 | 0.130 |
Why?
| | Qualitative Research | 1 | 2024 | 1720 | 0.120 |
Why?
| | Condoms | 2 | 2014 | 99 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 880 | 0.110 |
Why?
| | Patient Participation | 1 | 2019 | 454 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 104 | 0.110 |
Why?
| | Interpersonal Relations | 1 | 2018 | 387 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2020 | 486 | 0.110 |
Why?
| | Public Health Surveillance | 1 | 2015 | 84 | 0.110 |
Why?
| | Health Care Reform | 1 | 2015 | 109 | 0.110 |
Why?
| | Reproductive Health | 1 | 2015 | 94 | 0.110 |
Why?
| | Emergency Medical Services | 2 | 2020 | 680 | 0.110 |
Why?
| | Insurance Coverage | 2 | 2015 | 246 | 0.100 |
Why?
| | Machine Learning | 1 | 2020 | 590 | 0.100 |
Why?
| | Sexually Transmitted Diseases | 1 | 2015 | 163 | 0.100 |
Why?
| | Contact Tracing | 1 | 2012 | 26 | 0.090 |
Why?
| | Equivalence Trials as Topic | 2 | 2023 | 34 | 0.090 |
Why?
| | AIDS Serodiagnosis | 1 | 2012 | 23 | 0.090 |
Why?
| | Hepatitis C Antibodies | 1 | 2011 | 10 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2101 | 0.090 |
Why?
| | Risk Assessment | 2 | 2025 | 3678 | 0.080 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 96 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1531 | 0.080 |
Why?
| | Health Promotion | 1 | 2017 | 786 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2011 | 5875 | 0.070 |
Why?
| | ROC Curve | 1 | 2011 | 613 | 0.070 |
Why?
| | Urban Population | 2 | 2012 | 496 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2013 | 473 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2023 | 11744 | 0.060 |
Why?
| | Tape Recording | 1 | 2005 | 10 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1754 | 0.060 |
Why?
| | Harm Reduction | 1 | 2026 | 49 | 0.060 |
Why?
| | Monte Carlo Method | 1 | 2026 | 150 | 0.060 |
Why?
| | Delayed-Action Preparations | 1 | 2026 | 191 | 0.050 |
Why?
| | Life Expectancy | 1 | 2025 | 72 | 0.050 |
Why?
| | Bias | 1 | 2005 | 196 | 0.050 |
Why?
| | Alcoholism | 2 | 2020 | 830 | 0.050 |
Why?
| | Age Factors | 2 | 2009 | 3321 | 0.050 |
Why?
| | Risk Factors | 3 | 2019 | 10840 | 0.050 |
Why?
| | Hospitalization | 2 | 2026 | 2468 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 647 | 0.050 |
Why?
| | Logistic Models | 1 | 2008 | 2112 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2024 | 183 | 0.040 |
Why?
| | Sex Education | 1 | 2022 | 33 | 0.040 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 48 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2022 | 135 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 78 | 0.040 |
Why?
| | RNA, Viral | 1 | 2025 | 691 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2008 | 3633 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 413 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1866 | 0.040 |
Why?
| | Contraception | 1 | 2022 | 170 | 0.040 |
Why?
| | Oregon | 1 | 2020 | 83 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1843 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 216 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1070 | 0.030 |
Why?
| | Aged | 2 | 2016 | 26251 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2020 | 290 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 538 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2024 | 878 | 0.030 |
Why?
| | Gender Identity | 1 | 2018 | 132 | 0.030 |
Why?
| | Family | 1 | 2022 | 680 | 0.030 |
Why?
| | Self Efficacy | 1 | 2020 | 417 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 472 | 0.030 |
Why?
| | Minority Groups | 1 | 2018 | 285 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 942 | 0.030 |
Why?
| | Censuses | 1 | 2015 | 33 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 822 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1208 | 0.030 |
Why?
| | Cognition | 1 | 2002 | 1286 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 921 | 0.020 |
Why?
| | Antiviral Agents | 1 | 2019 | 774 | 0.020 |
Why?
| | Research Design | 1 | 2019 | 1139 | 0.020 |
Why?
| | Medical Assistance | 1 | 2012 | 13 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 140 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2012 | 267 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2008 | 17291 | 0.020 |
Why?
| | Comprehension | 1 | 2012 | 175 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2011 | 149 | 0.020 |
Why?
| | Saliva | 1 | 2011 | 256 | 0.020 |
Why?
| | Child | 2 | 2020 | 22638 | 0.020 |
Why?
| | Triage | 1 | 2012 | 243 | 0.020 |
Why?
| | Computers | 1 | 2009 | 65 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7217 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2009 | 74 | 0.020 |
Why?
| | Contraception Behavior | 1 | 2009 | 108 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2009 | 164 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 477 | 0.020 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2007 | 39 | 0.020 |
Why?
| | Urban Health | 1 | 2007 | 95 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 1062 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1992 | 0.020 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2005 | 91 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3396 | 0.010 |
Why?
|
|
Al-Tayyib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|